Modulation of the Vasopressin System in Distributive and Cardiogenic Shock: Theoretical Principles and Practical Applications - PubMed
6 hours ago
- #septic shock
- #decatecholaminization
- #vasopressin
- Vasodilatory shock, primarily from sepsis, is a leading ICU mortality cause with rates over 90% in refractory cases.
- Norepinephrine is the first-line vasopressor, but high doses can cause myocardial toxicity, arrhythmias, and immunodepression.
- Decatecholaminization uses non-adrenergic vasopressors like vasopressin to reduce catecholamine burden.
- Vasopressin acts on V1a and V2 receptors for vasoconstriction and water reabsorption, improving renal function.
- Clinical trials show vasopressin reduces the need for renal replacement therapy and benefits less severe shock cases.
- Terlipressin has a longer half-life but increases peripheral ischemia risk; selepressin aims to reduce fluid retention.
- Vasopressin system modulation is key in distributive and cardiogenic shock, protecting renal function and reducing arrhythmias.
- Future strategies may use biomarkers like copeptin and AI to optimize vasopressor therapy timing and selection.